title: Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
authors.affiliation: New England Deaconess Hospital, Boston, Massachusetts 02215, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Hale
authors.forename: R
authors.initials: R
authors.lastname: Gottschalk
authors.forename: M L
authors.initials: ML
authors.lastname: Wood
authors.forename: T
authors.initials: T
authors.lastname: Maki
authors.forename: A P
authors.initials: AP
authors.lastname: Monaco
mesh_terms: D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000627:therapeutic use*; D060908:CTLA-4 Antigen; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011090:Polyenes / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D020123:Sirolimus; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011090:Polyenes; D011993:Recombinant Fusion Proteins; D000069594:Abatacept; D016572:Cyclosporine; D020123:Sirolimus